Dr. Toshiyuki Oshitari is currently a professor at the
International University of Health and Welfare and a research professor in the
Chiba University Graduate School of Medicine. He received his MD from the
Kanazawa University School of Medicine in 1996 and his Ph.D. from the Chiba
University Graduate School of Medicine in 2002. From 2003 to 2005, he joined
the Boston University School of Medicine as a research fellow. He worked at the
Chiba University School of Medicine as an assistant professor from 2009 to 2011
and an associate professor (lecturer) from 2011 to 2018. Since 2018, he has
been working as a professor at the International University of Health and
Welfare and a research professor in the Chiba University Graduate School of
Medicine. He is a member of the Japanese Neuro-Ophthalmology Society, the Japan
Ophthalmologists Association, the Japan Ophthalmological Society, the Japan
Glaucoma Society, the European Association for Vision and Eye Research, and the Association for Research in Vision and Ophthalmology.
He is EBMs of Biomed Research International and International Journal of Molecular Science. His research interest is the elucidation of the precise mechanism of
the pathogenesis of diabetic neuropathy in the retina and the establishment of
neuroprotective and regenerative therapies for diabetic retinopathy.
Dr. Toshiyuki Oshitari is currently a professor at the
International University of Health and Welfare and a research professor in the
Chiba University Graduate School of Medicine. He received his MD from the
Kanazawa University School of Medicine in 1996 and his Ph.D. from the Chiba
University Graduate School of Medicine in 2002. From 2003 to 2005, he joined
the Boston University School of Medicine as a research fellow. He worked at the
Chiba University School of Medicine as an assistant professor from 2009 to 2011
and an associate professor (lecturer) from 2011 to 2018. Since 2018, he has
been working as a professor at the International University of Health and
Welfare and a research professor in the Chiba University Graduate School of
Medicine. He is a member of the Japanese Neuro-Ophthalmology Society, the Japan
Ophthalmologists Association, the Japan Ophthalmological Society, the Japan
Glaucoma Society, the European Association for Vision and Eye Research, and the Association for Research in Vision and Ophthalmology.
He is EBMs of Biomed Research International and International Journal of Molecular Science. His research interest is the elucidation of the precise mechanism of
the pathogenesis of diabetic neuropathy in the retina and the establishment of
neuroprotective and regenerative therapies for diabetic retinopathy.